relistor
bausch health ireland limited - metyylinaltreksonibromidia - opioid-related disorders; constipation - reuna-opioidi-reseptorin antagonistit - opioidilla indusoidun ummetuksen hoito kehittyneissä sairauksissa potilailla, jotka saavat palliatiivista hoitoa, kun vastaus tavalliseen laksatiiviseen hoitoon ei ole ollut riittävä.
temgesic 0.3 mg/ml injektioneste, liuos
eumedica pharmaceuticals gmbh - buprenorphine hydrochloride - injektioneste, liuos - 0.3 mg/ml - buprenorfiini
temgesic 0.2 mg resoribletti
eumedica pharmaceuticals gmbh - buprenorphine hydrochloride - resoribletti - 0.2 mg - buprenorfiini
temgesic 0.4 mg resoribletti
eumedica pharmaceuticals gmbh - buprenorphine hydrochloride - resoribletti - 0.4 mg - buprenorfiini
bunalict 2 mg / 0,5 mg resoribletti
sandoz a/s - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - resoribletti - 2 mg / 0,5 mg - buprenorfiini
bunalict 8 mg / 2 mg resoribletti
sandoz a/s - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - resoribletti - 8 mg / 2 mg - buprenorfiini
buprenorphine/naloxone g.l. pharma 2 mg / 0,5 mg resoribletti
g.l. pharma gmbh - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - resoribletti - 2 mg / 0,5 mg - buprenorfiini
buprenorphine/naloxone g.l. pharma 4 mg / 1 mg resoribletti
g.l. pharma gmbh - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - resoribletti - 4 mg / 1 mg - buprenorfiini
buprenorphine/naloxone g.l. pharma 8 mg / 2 mg resoribletti
g.l. pharma gmbh - buprenorphine hydrochloride, naloxone hydrochloride dihydrate - resoribletti - 8 mg / 2 mg - buprenorfiini
buprenorphine/naloxone mylan 2 mg / 0,5 mg resoribletti
mylan ab - naloxone hydrochloride dihydrate, buprenorphine hydrochloride - resoribletti - 2 mg / 0,5 mg - buprenorfiini